These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38065310)

  • 1. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia.
    Wymer KM; Thao V; Narang G; Sharma V; Borah BJ; Cheney S; Humphreys MR
    Urology; 2024 Feb; 184():87-93. PubMed ID: 38065310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.
    Sahakyan Y; Erman A; Bhojani N; Chughtai B; Zorn KC; Sander B; Elterman DS
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):113-118. PubMed ID: 35689083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.
    Prudhomme T; Marquette T; Péré M; Patard PM; Michiels C; Sallusto F; Rigaud J; Glémain P; Kamar N; Blancho G; Soulié M; Rischmann P; Karam G; Gamé X; Robert G; Branchereau J
    J Endourol; 2020 Feb; 34(2):184-191. PubMed ID: 31588793
    [No Abstract]   [Full Text] [Related]  

  • 6. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Fu S; Bhattacharyya SK; El-Arabi AM; Cutone BJ; McVary KT
    PLoS One; 2022; 17(4):e0266824. PubMed ID: 35427376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
    Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
    J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia.
    Wymer KM; Narang G; Slade A; Sharma V; Thao V; Borah BJ; Rivera M; Cheney S; Humphreys MR
    Urology; 2023 Jan; 171():96-102. PubMed ID: 36270339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
    Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
    Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
    De la Cuadra-Grande A; Rioja-Zuazu J; Domínguez-Esteban M; Torres E; Blissett R; Woodward E; Oyagüez I; Fernández-Arjona M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):499-510. PubMed ID: 36897833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative and economic analysis of surgical treatments for benign prostatic hyperplasia: A study of the French committee on LUT.
    Mathieu R; Lebdai S; Cornu JN; Benchikh A; Azzouzi AR; Delongchamps NB; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Misrai V; de La Taille A; Robert G; Descazeaud A
    Prog Urol; 2017 May; 27(6):362-368. PubMed ID: 28495071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Perioperative Outcomes Across Major Benign Prostatic Hyperplasia Procedures from the ACS-NSQIP 2011-2015.
    Anderson BB; Heiman J; Large T; Lingeman J; Krambeck A
    J Endourol; 2019 Jan; 33(1):62-68. PubMed ID: 30039715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia surgical re-treatment after prostatic urethral lift A narrative review.
    Dean NS; Assmus MA; Lee MS; Guo JN; Krambeck AE
    Can Urol Assoc J; 2023 Oct; 17(10):353-359. PubMed ID: 37494319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Amorosi SL; Shore ND
    J Health Econ Outcomes Res; 2021 May; 8(1):42-50. PubMed ID: 33987450
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
    Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
    He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
    Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign Prostatic Hyperplasia Surgery: A Snapshot of Trends, Costs, and Surgical Retreatment Rates in the USA.
    Ditonno F; Manfredi C; Licari LC; Bologna E; Franco A; Pandolfo SD; De Sio M; De Nunzio C; Fiori C; Cherullo EE; Olweny EO; Antonelli A; Autorino R
    Eur Urol Focus; 2024 Apr; ():. PubMed ID: 38670842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holmium Laser Enucleation of the Prostate Following Previous Prostatic Urethral Lift.
    Das A; Han TM; Rudnick B; Hardacker T; Shenot PJ; Shvero A
    J Endourol; 2022 Jan; 36(1):111-116. PubMed ID: 34235977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.